Suchergebnisse - "Cook, Gordon"

PubPharm (20)

1

Treatment of relapsed and refractory multiple myeloma : recommendations from the International Myeloma Working Group

enthalten in: The Lancet. Oncology | 2021

von Moreau, P. | Kumar, S. | San Miguel, J. | +67

2

Management of patients with multiple myeloma beyond the clinical-trial setting : understanding the balance between efficacy, safety and tolerability, and quality of life

enthalten in: Blood cancer journal | 2021

von Terpos, E. | Mikhael, J. | Hajek, R. | +13

3

Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy

enthalten in: British journal of haematology | 2020

von Cook, G. | John Ashcroft, A. | Pratt, G. | +14

4

RNA-seq of newly diagnosed patients in the PADIMAC study leads to a bortezomib/lenalidomide decision signature

enthalten in: Blood | 2018

von Chapman, M. | Sive, J. | Ambrose, J. | +27

CommentIn: Blood. 2018 Nov 15;132(20):2110-2111. - PMID 30442746

5

Prevention and management of adverse events of novel agents in multiple myeloma : a consensus of the European Myeloma Network

enthalten in: Leukemia | 2018

von Ludwig, H. | Delforge, M. | Facon, T. | +29

6

The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial) : study protocol for a Phase III randomised controlled trial

enthalten in: Trials | 2018

von Striha, A. | Ashcroft, A. | Hockaday, A. | +12

7

A question of class : Treatment options for patients with relapsed and/or refractory multiple myeloma

enthalten in: Critical reviews in oncology/hematology | 2018

von Cook, G. | Zweegman, S. | Mateos, M. | +2

8

Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

enthalten in: Drugs | 2016

von Moreau, P. | van de Donk, N. | San Miguel, J. | +17

ErratumIn: Drugs. 2016 Jun;76(9):989-90. - PMID 27206917

9

Long-term follow-up of MRC Myeloma IX trial : Survival outcomes with bisphosphonate and thalidomide treatment

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2013

von Morgan, G. | Davies, F. | Gregory, W. | +8

10

The impact of response on bone-directed therapy in patients with multiple myeloma

enthalten in: Blood | 2013

von Larocca, A. | Child, J. | Cook, G. | +12